481 Four-week Therapy With Peginterferon Alfa-2b/ Ribavirin Effectively Predicts Sustained Virologic Response in Treatment-naive and Previous-treatment-failure Patients With Hcv-1 Treated With Boceprevir Plus Peginterferon Alfa-2b/ribavirin
Year: 2011
Type: article
Source: Journal of Hepatology
Institutions: Baylor College of Medicine, Rega Institute for Medical Research, Gilead Sciences (United States), Cedars-Sinai Medical Center, Universität Innsbruck, Hôpital Saint Joseph, Vall d'Hebron Hospital Universitari, University of Ottawa, Ottawa Hospital, Merck & Co., Inc., Rahway, NJ, USA (United States), Azienda Ospedaliera Fatebenefratelli e Oftalmico
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2267900261